Search Clinical Trials
589,087 trials
ID
Status
Phase
Title
Sponsor
NCT07645209
A Real-world Study of Immunotherapy Combination Regimens for Treating Liver Cancer in Cold RegionsChina-Japan Union Hospital, Jilin UniversityActive Not Recruiting
NCT07645209Active Not Recruiting
—
A Real-world Study of Immunotherapy Combination Regimens for Treating Liver Canc...China-Japan Union Hospita...
NCT07646353
First-in-Human Dose-escalation of GSK4425689A: Safety, Tolerability, and PK in Healthy AdultsGlaxoSmithKlineNot Yet RecruitingPhase 1
NCT07646353Not Yet Recruiting
Phase 1
First-in-Human Dose-escalation of GSK4425689A: Safety, Tolerability, and PK in H...GlaxoSmithKline
NCT07645846
Neoadjuvant Docetaxel, Cisplatin, and Dual Immunotherapy for Sinonasal CarcinomaFirst Affiliated Hospital, Sun Yat-Sen UniversityNot Yet RecruitingPhase 2
NCT07645846Not Yet Recruiting
Phase 2
Neoadjuvant Docetaxel, Cisplatin, and Dual Immunotherapy for Sinonasal CarcinomaFirst Affiliated Hospital...
NCT07646288
Acute Effects of Visual Feedback-Assisted Inspiratory Muscle Training After LobectomyHacettepe UniversityRecruitingNot Applicable
NCT07646288Recruiting
Not Applicable
Acute Effects of Visual Feedback-Assisted Inspiratory Muscle Training After Lobe...Hacettepe University
NCT07646418
Combined Effects of LIRT-BFR Therapy in Post- Stroke PatientsRiphah International UniversityRecruitingNot Applicable
NCT07646418Recruiting
Not Applicable
Combined Effects of LIRT-BFR Therapy in Post- Stroke PatientsRiphah International Univ...
NCT07644208
PD-1/IL-2 Bispecific Antibody as Neoadjuvant Therapy for Early Recurrent Hepatocellular Carcinoma After Curative HepatectomyShanghai Zhongshan HospitalNot Yet RecruitingPhase 2
NCT07644208Not Yet Recruiting
Phase 2
PD-1/IL-2 Bispecific Antibody as Neoadjuvant Therapy for Early Recurrent Hepatoc...Shanghai Zhongshan Hospit...
NCT07645222
PHASE 1b STUDY OF HS-20122 COMBINED THERAPY IN NSCLCHansoh BioMedical R&D CompanyNot Yet RecruitingPhase 1
NCT07645222Not Yet Recruiting
Phase 1
PHASE 1b STUDY OF HS-20122 COMBINED THERAPY IN NSCLCHansoh BioMedical R&D Com...
NCT07643818
Intravenous Iron to Improve Symptoms, Quality of Life and Exercise Capacity in HFpEF With Iron DeficiencyGovernment of JerseyNot Yet RecruitingPhase 2
NCT07643818Not Yet Recruiting
Phase 2
Intravenous Iron to Improve Symptoms, Quality of Life and Exercise Capacity in H...Government of Jersey
NCT07645183
Advanced Technology for Myopia Control in Children and Young AdultsUniversity of FaisalabadCompletedNot Applicable
NCT07645183Completed
Not Applicable
Advanced Technology for Myopia Control in Children and Young AdultsUniversity of Faisalabad
NCT07645508
Comparison of Conventional, Patient-Specific, and Augmented Reality Navigation in Reverse Total Shoulder ArthroplastyKrankenhaus Barmherzige Schwestern LinzActive Not Recruiting
NCT07645508Active Not Recruiting
—
Comparison of Conventional, Patient-Specific, and Augmented Reality Navigation i...Krankenhaus Barmherzige S...
NCT07644351
A Real-world Study of Asciminib Effectiveness in Philadelphia Positive Acute Lymphoblastic Leukemia PatientsNovartis PharmaceuticalsCompleted
NCT07644351Completed
—
A Real-world Study of Asciminib Effectiveness in Philadelphia Positive Acute Lym...Novartis Pharmaceuticals
NCT07644559
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic CancerVerastem, Inc.RecruitingPhase 2
NCT07644559Recruiting
Phase 2
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic CancerVerastem, Inc.
NCT07645612
A Just-in-Time Digital Learning Platform for Teacher Oral Health TrainingUniversiti Putra MalaysiaNot Yet RecruitingNot Applicable
NCT07645612Not Yet Recruiting
Not Applicable
A Just-in-Time Digital Learning Platform for Teacher Oral Health TrainingUniversiti Putra Malaysia
NCT07644897
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaSun Yat-sen UniversityRecruitingPhase 2
NCT07644897Recruiting
Phase 2
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients...Sun Yat-sen University
NCT07646535
A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Primary AldosteronismShenzhen Salubris Pharmaceuticals Co., Ltd.Not Yet RecruitingPhase 2
NCT07646535Not Yet Recruiting
Phase 2
A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses i...Shenzhen Salubris Pharmac...
NCT07646379
Effects of Spinal Mobilization With Leg Movement With and Without Neural Flossing Technique in Lumbar RadiculopathyRiphah International UniversityNot Yet RecruitingNot Applicable
NCT07646379Not Yet Recruiting
Not Applicable
Effects of Spinal Mobilization With Leg Movement With and Without Neural Flossin...Riphah International Univ...
NCT07645924
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of MigraineKallyope Inc.Not Yet RecruitingPhase 3
NCT07645924Not Yet Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute T...Kallyope Inc.
Result Breakdown
Not yet recruiting11 (55%)
Recruiting4 (20%)
Completed3 (15%)
Active, not recruiting2 (10%)
Phase 26 (30%)
not_applicable6 (30%)
Not Specified4 (20%)
Phase 13 (15%)
Phase 31 (5%)